Advertisement
CE vs CVS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CE is a Hold and CVS is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CE’s FA Score shows that 0 FA rating(s) are green whileCVS’s FA Score has 2 green FA rating(s).
- CE’s FA Score: 0 green, 5 red.
- CVS’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CE’s TA Score shows that 3 TA indicator(s) are bullish while CVS’s TA Score has 4 bullish TA indicator(s).
- CE’s TA Score: 3 bullish, 5 bearish.
- CVS’s TA Score: 4 bullish, 6 bearish.
Price Growth
CE (@Chemicals: Specialty) experienced а -6.10% price change this week, while CVS (@Managed Health Care) price change was -4.35% for the same time period.
The average weekly price growth across all stocks in the @Chemicals: Specialty industry was -0.23%. For the same industry, the average monthly price growth was +3.52%, and the average quarterly price growth was +2.54%.
The average weekly price growth across all stocks in the @Managed Health Care industry was -6.03%. For the same industry, the average monthly price growth was -13.86%, and the average quarterly price growth was -20.62%.
Reported Earning Dates
CE is expected to report earnings on Nov 10, 2025.
CVS is expected to report earnings on Oct 29, 2025.
Industries' Descriptions
@Chemicals: Specialty (-0.23% weekly)The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.
@Managed Health Care (-6.03% weekly)Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
| CE | CVS | CE / CVS | |
| Capitalization | 19.2B | 100B | 19% |
| EBITDA | 2.64B | 18.2B | 15% |
| Gain YTD | -17.090 | 41.222 | -41% |
| P/E Ratio | 9.51 | 12.33 | 77% |
| Revenue | 10.9B | 358B | 3% |
| Total Cash | 1.81B | 11.5B | 16% |
| Total Debt | 14.1B | 79.4B | 18% |
CE | CVS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 53 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 49 Fair valued | 2 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 87 | |
SMR RATING 1..100 | 95 | 79 | |
PRICE GROWTH RATING 1..100 | 55 | 58 | |
P/E GROWTH RATING 1..100 | 69 | 18 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CVS's Valuation (2) in the Drugstore Chains industry is somewhat better than the same rating for CE (49) in the Chemicals Major Diversified industry. This means that CVS’s stock grew somewhat faster than CE’s over the last 12 months.
CVS's Profit vs Risk Rating (87) in the Drugstore Chains industry is in the same range as CE (100) in the Chemicals Major Diversified industry. This means that CVS’s stock grew similarly to CE’s over the last 12 months.
CVS's SMR Rating (79) in the Drugstore Chains industry is in the same range as CE (95) in the Chemicals Major Diversified industry. This means that CVS’s stock grew similarly to CE’s over the last 12 months.
CE's Price Growth Rating (55) in the Chemicals Major Diversified industry is in the same range as CVS (58) in the Drugstore Chains industry. This means that CE’s stock grew similarly to CVS’s over the last 12 months.
CVS's P/E Growth Rating (18) in the Drugstore Chains industry is somewhat better than the same rating for CE (69) in the Chemicals Major Diversified industry. This means that CVS’s stock grew somewhat faster than CE’s over the last 12 months.
| CE | CVS | |
|---|---|---|
| RSI ODDS (%) | 6 days ago 58% | 3 days ago 57% |
| Stochastic ODDS (%) | 3 days ago 69% | 3 days ago 61% |
| Momentum ODDS (%) | 3 days ago 63% | 3 days ago 54% |
| MACD ODDS (%) | 3 days ago 72% | 3 days ago 54% |
| TrendWeek ODDS (%) | 3 days ago 65% | 3 days ago 58% |
| TrendMonth ODDS (%) | 3 days ago 63% | 3 days ago 53% |
| Advances ODDS (%) | 11 days ago 65% | 20 days ago 63% |
| Declines ODDS (%) | 5 days ago 67% | 3 days ago 58% |
| BollingerBands ODDS (%) | 3 days ago 67% | 3 days ago 72% |
| Aroon ODDS (%) | 3 days ago 59% | 3 days ago 67% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IBHG | 22.44 | 0.02 | +0.08% |
| iShares® iBonds® 2027 Term HY & Inc ETF | |||
| BOUT | 37.33 | N/A | N/A |
| Innovator IBD® Breakout Opps ETF | |||
| BALT | 32.24 | -0.02 | -0.06% |
| Innovator Defined Wealth Shld ETF | |||
| USOY | 9.15 | -0.01 | -0.11% |
| Defiance Oil Enhanced Options Income ETF | |||
| PHDG | 35.66 | -0.05 | -0.15% |
| Invesco S&P 500® Downside Hedged ETF | |||
CVS and
Correlation & Price change
A.I.dvisor indicates that over the last year, CVS has been loosely correlated with CNC. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CVS jumps, then CNC could also see price increases.